Antibiotics Sector: Growth Drivers and Challenges
Growth Drivers
- Growing Prevalence of Respiratory Diseases - The respiratory system is a group of organs that regulates breathing. The lungs are the system's main organ, and it also consists of the pharynx, larynx, trachea, nasal tube, oral cavity, pharynx, and bronchi and bronchioles. Respiratory diseases are one of the leading causes of death worldwide. These diseases need a preferred dose of antibiotics to control the further spread of bacteria. Therefore, growing prevalence of respiratory diseases is fueling up the antibiotics market growth. As per the World Health Organization statistics, globally, nearly 262 million individuals have been suffering from asthma.
- Surge in Drug Combinations Over Mono-Therapy – It was observed in a clinical study that a database for antifungal therapy has nearly 5,517 medicines in 8,129 combinations that have been evaluated against 240 strains, yielding 491,126 samples.
- Escalation in Urinary Tract Infections (UTIs) – For instance, every year, more than 8 million patients with urinary tract infections (UTIs) seek medical treatment. About 61% of women and 13% of men are predicted to get at least one UTI in their lives.
- Boost in Global Burden of Bacterial Skin Diseases – Globally, the age-standardized estimated incidence of bacterial skin diseases was reached around 161 million for males and 133 million for females in 2019.
- Growing Number of Older-Aged Population - According to the statistics of World Health Organization, the global population of people aged 60 and up is projected to increase from 1 billion in 2020 to 1.4 billion by 2030.
Challenges
- Side Effects Associated with Antibiotics - Antibiotic side effects can include allergic reactions and severe, sometimes fatal diarrhea brought on by the bacterium Clostridium difficile (C. diff). Additionally, antibiotics may conflict with other medications.
- Stringent Regulatory Procedures
- Escalation in Antibiotic Resistance
Antibiotics Market: Key Insights
Base Year |
2024 |
Forecast Year |
2025-2037 |
CAGR |
8.4% |
Base Year Market Size (2024) |
USD 50.55 billion |
Forecast Year Market Size (2037) |
USD 144.25 billion |
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Antibiotics Market in 2025 is assessed at USD 53.95 billion.
The global market size was valued at over USD 50.55 billion in 2024 and is expected to expand at a CAGR of around 8.4%, surpassing USD 144.25 billion revenue by 2037.
Asia Pacific is forecast to exceed majority share by 2037, driven by growing prevalence of infectious diseases, increasing antibiotic consumption, and a rapidly growing population.
The major players in the market include F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Bristol-Myers Squibb Company, Teva Pharmaceuticals Industries Ltd., Pfizer Inc., Abbott Laboratories, Merck & Co., Inc., Lupin Limited, Melinta Therapeutics, LLC, Bayer AG.